BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37938598)

  • 21. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer.
    Berg S; Cole AP; Krimphove MJ; Nabi J; Marchese M; Lipsitz SR; Noldus J; Choueiri TK; Kibel AS; Trinh QD
    Eur Urol; 2019 Apr; 75(4):552-555. PubMed ID: 30420255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness of treatments for high-risk prostate cancer patients.
    Jayadevappa R; Lee DI; Chhatre S; Guzzo TJ; Malkowicz SB
    Urol Oncol; 2019 Sep; 37(9):574.e11-574.e18. PubMed ID: 31285113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-year treatment complication outcomes of radical prostatectomy vs external beam radiation vs brachytherapy for 1503 patients with intermediate risk prostate cancer.
    Goy BW; Burchette R
    Brachytherapy; 2021; 20(6):1083-1089. PubMed ID: 34090815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
    Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
    Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges in the Analysis of Outcomes for Surgical Compared to Radiotherapy Treatment of Prostate Cancer.
    Glaser SM; Kalash R; Bongiorni DR; Roberts MS; Balasubramani GK; Jacobs BL; Beriwal S; Heron DE; Greenberger JS
    In Vivo; 2018; 32(1):113-120. PubMed ID: 29275307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
    Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
    BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.
    Gray PJ; Lin CC; Cooperberg MR; Jemal A; Efstathiou JA
    Eur Urol; 2017 May; 71(5):729-737. PubMed ID: 27597241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
    Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
    Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer.
    Goy BW; Burchette R; Soper MS; Chang T; Cosmatos HA
    Urology; 2020 Feb; 136():180-189. PubMed ID: 31704459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.
    Kishan AU; Shaikh T; Wang PC; Reiter RE; Said J; Raghavan G; Nickols NG; Aronson WJ; Sadeghi A; Kamrava M; Demanes DJ; Steinberg ML; Horwitz EM; Kupelian PA; King CR
    Eur Urol; 2017 May; 71(5):766-773. PubMed ID: 27452951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis.
    Wang Z; Ni Y; Chen J; Sun G; Zhang X; Zhao J; Zhu X; Zhang H; Zhu S; Dai J; Shen P; Zeng H
    World J Surg Oncol; 2020 Feb; 18(1):42. PubMed ID: 32093688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada.
    Wettstein MS; Palmer KS; Kulkarni GS; Paterson JM; Ling V; Lapointe-Shaw L; Li AH; Brown A; Taljaard M; Ivers N
    JAMA Netw Open; 2019 Aug; 2(8):e1910505. PubMed ID: 31469400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.
    Nepple KG; Stephenson AJ; Kallogjeri D; Michalski J; Grubb RL; Strope SA; Haslag-Minoff J; Piccirillo JF; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Kibel AS
    Eur Urol; 2013 Sep; 64(3):372-8. PubMed ID: 23506834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy.
    Guo Y; Mao S; Zhang A; Zhang J; Wang L; Wang R; Zhang W; Zhang Z; Wu Y; Cao X; Yang B; Yao X
    Front Oncol; 2019; 9():638. PubMed ID: 31380277
    [No Abstract]   [Full Text] [Related]  

  • 36. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overactive bladder syndrome: an underestimated long-term problem after treatment of patients with localized prostate cancer?
    Boettcher M; Haselhuhn A; Jakse G; Brehmer B; Kirschner-Hermanns R
    BJU Int; 2012 Jun; 109(12):1824-30. PubMed ID: 21952039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatments for prostate cancer in older men: 1984-1997.
    Bubolz T; Wasson JH; Lu-Yao G; Barry MJ
    Urology; 2001 Dec; 58(6):977-82. PubMed ID: 11744472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between surgeon and hospital characteristics and lymph node counts from radical prostatectomy and pelvic lymph node dissection.
    Wang EH; Yu JB; Gross CP; Abouassaly R; Cherullo EE; Smaldone MC; Shah ND; Kiechle J; Trinh QD; Sun M; Kim SP
    Urology; 2015 Apr; 85(4):890-5. PubMed ID: 25817114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
    Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.